Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases

Purpose: To investigate features and outcomes of circumscribed choroidal hemangioma by patient age. Methods: Retrospective review of circumscribed choroidal hemangioma from 3/29/1967–6/4/2018 based on age at presentation (≤20 vs. >20–50 vs. >50 years). Results: There were 458 circumscribed cho...

Full description

Bibliographic Details
Main Authors: Lauren A. Dalvin, Li-Anne S. Lim, Michael Chang, Sanika Udyaver, Mehdi Mazloumi, Pornpattana Vichitvejpaisal, Grace L. Su, Eleni Florakis, Arman Mashayekhi, Jerry A. Shields, Carol L. Shields
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-07-01
Series:Saudi Journal of Ophthalmology
Online Access:http://www.sciencedirect.com/science/article/pii/S1319453419300384
id doaj-3912bceb43654916b9901fa3b517daae
record_format Article
spelling doaj-3912bceb43654916b9901fa3b517daae2021-04-02T20:12:39ZengWolters Kluwer Medknow PublicationsSaudi Journal of Ophthalmology1319-45342019-07-01333219228Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 casesLauren A. Dalvin0Li-Anne S. Lim1Michael Chang2Sanika Udyaver3Mehdi Mazloumi4Pornpattana Vichitvejpaisal5Grace L. Su6Eleni Florakis7Arman Mashayekhi8Jerry A. Shields9Carol L. Shields10Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United States; Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United States; Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, ThailandOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United StatesOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United States; Corresponding author.Purpose: To investigate features and outcomes of circumscribed choroidal hemangioma by patient age. Methods: Retrospective review of circumscribed choroidal hemangioma from 3/29/1967–6/4/2018 based on age at presentation (≤20 vs. >20–50 vs. >50 years). Results: There were 458 circumscribed choroidal hemangiomas diagnosed at mean age (13 vs. 41 vs. 64 years, p < 0.001). The youngest age group had worse presenting visual acuity (20/400 vs. 20/150 vs. 20/100, p < 0.001), larger tumor basal diameter (13.5 vs. 6.6 vs. 6.2, p < 0.001), greater tumor thickness (5.8 vs. 3.1 vs. 2.9, p < 0.001), closer distance to foveola (0.5 vs. 1.4 vs. 1.2, p = 0.03), and greater extent of subretinal fluid (4 quadrants, 26% vs. 8% vs. 2%, p < 0.001). The youngest patients were less likely to be treated with primary observation (39% vs. 39% vs. 56%) or photodynamic therapy (10% vs. 27% vs. 22%) and more likely to be treated with plaque radiotherapy (26% vs. 6% vs. 3%) or external beam radiotherapy (13% vs. 1% vs. 0%) (p < 0.001). The youngest patients required greater total number of treatments (mean 4 vs. 2 vs. 1, p < 0.001). At mean follow-up (44 vs. 68 vs. 60 months, p = 0.37), the youngest patients had worse visual acuity (20/400 vs. 20/200 vs. 20/100, p = 0.03), but no difference in visual acuity loss of 3 or more Snellen lines (27% vs. 13% vs. 16%, p = 0.55). Conclusion: Younger patients (≤20 years) with circumscribed choroidal hemangioma present with worse visual acuity and larger, more posterior tumors. Future studies are needed to improve early detection and treatment for this subgroup of patients. Keywords: Eye, Choroid, Tumor, Hemangioma, Circumscribed, Agehttp://www.sciencedirect.com/science/article/pii/S1319453419300384
collection DOAJ
language English
format Article
sources DOAJ
author Lauren A. Dalvin
Li-Anne S. Lim
Michael Chang
Sanika Udyaver
Mehdi Mazloumi
Pornpattana Vichitvejpaisal
Grace L. Su
Eleni Florakis
Arman Mashayekhi
Jerry A. Shields
Carol L. Shields
spellingShingle Lauren A. Dalvin
Li-Anne S. Lim
Michael Chang
Sanika Udyaver
Mehdi Mazloumi
Pornpattana Vichitvejpaisal
Grace L. Su
Eleni Florakis
Arman Mashayekhi
Jerry A. Shields
Carol L. Shields
Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases
Saudi Journal of Ophthalmology
author_facet Lauren A. Dalvin
Li-Anne S. Lim
Michael Chang
Sanika Udyaver
Mehdi Mazloumi
Pornpattana Vichitvejpaisal
Grace L. Su
Eleni Florakis
Arman Mashayekhi
Jerry A. Shields
Carol L. Shields
author_sort Lauren A. Dalvin
title Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases
title_short Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases
title_full Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases
title_fullStr Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases
title_full_unstemmed Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases
title_sort circumscribed choroidal hemangioma: clinical features and outcomes by age category in 458 cases
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Ophthalmology
issn 1319-4534
publishDate 2019-07-01
description Purpose: To investigate features and outcomes of circumscribed choroidal hemangioma by patient age. Methods: Retrospective review of circumscribed choroidal hemangioma from 3/29/1967–6/4/2018 based on age at presentation (≤20 vs. >20–50 vs. >50 years). Results: There were 458 circumscribed choroidal hemangiomas diagnosed at mean age (13 vs. 41 vs. 64 years, p < 0.001). The youngest age group had worse presenting visual acuity (20/400 vs. 20/150 vs. 20/100, p < 0.001), larger tumor basal diameter (13.5 vs. 6.6 vs. 6.2, p < 0.001), greater tumor thickness (5.8 vs. 3.1 vs. 2.9, p < 0.001), closer distance to foveola (0.5 vs. 1.4 vs. 1.2, p = 0.03), and greater extent of subretinal fluid (4 quadrants, 26% vs. 8% vs. 2%, p < 0.001). The youngest patients were less likely to be treated with primary observation (39% vs. 39% vs. 56%) or photodynamic therapy (10% vs. 27% vs. 22%) and more likely to be treated with plaque radiotherapy (26% vs. 6% vs. 3%) or external beam radiotherapy (13% vs. 1% vs. 0%) (p < 0.001). The youngest patients required greater total number of treatments (mean 4 vs. 2 vs. 1, p < 0.001). At mean follow-up (44 vs. 68 vs. 60 months, p = 0.37), the youngest patients had worse visual acuity (20/400 vs. 20/200 vs. 20/100, p = 0.03), but no difference in visual acuity loss of 3 or more Snellen lines (27% vs. 13% vs. 16%, p = 0.55). Conclusion: Younger patients (≤20 years) with circumscribed choroidal hemangioma present with worse visual acuity and larger, more posterior tumors. Future studies are needed to improve early detection and treatment for this subgroup of patients. Keywords: Eye, Choroid, Tumor, Hemangioma, Circumscribed, Age
url http://www.sciencedirect.com/science/article/pii/S1319453419300384
work_keys_str_mv AT laurenadalvin circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT lianneslim circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT michaelchang circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT sanikaudyaver circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT mehdimazloumi circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT pornpattanavichitvejpaisal circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT gracelsu circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT eleniflorakis circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT armanmashayekhi circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT jerryashields circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
AT carollshields circumscribedchoroidalhemangiomaclinicalfeaturesandoutcomesbyagecategoryin458cases
_version_ 1714700797491544064